Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Companyâ€™s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Companyâ€™s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	3.83M 3.36M 3.13M 2.87M 5.39M 369M 5.48M 37.14M 14.51M 181M 14.37M 14.06M 627M	P/E 2023	40.3x	P/E 2024	89x
Enterprise Value	38.02M 33.39M 31.06M 28.5M 53.55M 3.66B 54.37M 369M 144M 1.8B 143M 140M 6.22B	EV / Sales 2023	2.17x	EV / Sales 2024	1.5x
Free-Float	38.37%	Yield 2023 *	-	Yield 2024	-

27/03	Altivera Medical Holdings, LLC acquired Zynex, Inc.	CI
27/03	Zynex, Inc. Secures Term Loan Credit Agreement Finalized	CI
26/03	Zynex, Inc. Emerged from Bankruptcy	CI
21/03	Court confirms Zynex plan of reorganization on March 19, 2026 - SEC filing	RE
19/03	Third Amended Reorganization Plan Approved for Zynex, Inc.	CI
20/02	Zynex Inc says SEC concluded investigation into Zynex, no enforcement action planned	RE
18/02	Zynex Inc resolves federal investigation into business practices	RE
10/02	Notice of Auction Cancellation and Designation of Successful Bidder Filed by Zynex, Inc.	CI
07/02	Third Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
05/02	Zynex, Inc. Announces New In-Network Provider Status with Humana	CI
02/02	Second Amended Joint Disclosure Statement Conditionally Approved and Combined Hearing of Second Amended Disclosure Statement and Reorganization Plan Approved for Zynex, Inc.	CI
01/02	Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
29/01	First Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI

01/08/25	RBC Capital Adjusts Price Target on Zynex to $2 From $3, Maintains Sector Perform Rating	MT
01/08/25	HC Wainwright Downgrades Zynex to Neutral From Buy	MT
01/08/25	Medtech Zynex's Q2 revenue falls more than expected, names new CEO, suspends forecast	RE
15/07/25	RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating	MT
30/04/25	RBC Cuts Price Target on Zynex to $4 From $5, Keeps Sector Perform Rating	MT

28/03	ZYXIQ Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
27/03	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR
27/03	ZYXIQ SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
26/03	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Zynex, Inc. Lawsuit - ZYXIQ	PR
25/03	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR

27/12/22	Top 50 Small-caps 2023
21/12/22	Top 50 Small-caps 2023
22/10/21	Los valores del Nasdaq con mayor crecimiento
21/10/21	Les actions du Nasdaq avec la plus forte croissance

Zynex Inc. Stock OTC Bulletin Board

Stocks

Advanced Medical Equipment & Technology

Valuation: Zynex Inc.

Latest news : Zynex Inc.

Last Transcript: Zynex Inc.

Analysts' recommendations: Zynex Inc.

Press Releases: Zynex Inc.

News in other languages: Zynex Inc.

Managers and Directors: Zynex Inc.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Manager	Title	Age	Since
Steven Dyson CEO	Chief Executive Officer	53	18/08/2025
Vikram Bajaj DFI	Director of Finance/CFO	50	18/08/2025
John Bibb LAW	General Counsel	53	18/08/2025

Director	Title	Age	Since
Vikram Bajaj BRD	Director/Board Member	50	26/03/2026
John Bibb BRD	Director/Board Member	53	26/03/2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZYNEX INC.	-.--%	-.--%	-	-	1.69M
THERMO FISHER SCIENTIFIC, INC.	-0.71%	+6.72%	+18.80%	-0.46%	211B
DANAHER CORPORATION	-0.52%	-6.05%	-6.80%	-25.11%	135B
INTUITIVE SURGICAL, INC.	+1.65%	-2.29%	-31.94%	+1.99%	119B
BOSTON SCIENTIFIC CORPORATION	+1.54%	+0.50%	-58.31%	-15.57%	65.77B
EDWARDS LIFESCIENCES CORPORATION	-1.42%	-3.62%	+3.29%	-9.87%	47.58B
SIEMENS HEALTHINEERS AG	+3.03%	-0.17%	-26.91%	-33.60%	44.44B
AGILENT TECHNOLOGIES, INC.	-0.84%	+5.41%	+15.30%	+8.84%	39.14B
WATERS CORPORATION	-2.02%	+1.54%	+23.68%	+30.76%	36.79B
ILLUMINA, INC.	-1.41%	+3.99%	+77.58%	+2.50%	29.37B
Average	-0.07%	+0.47%	+1.63%	-4.50%	80.9B
Weighted average by Cap.	-0.00%	+0.37%	-2.58%	-6.42%

	2023	2024
Net sales	184M 162M 151M 138M 260M 17.75B 264M 1.79B 698M 8.73B 692M 677M 30.17B	192M 169M 157M 144M 271M 18.52B 275M 1.87B 729M 9.11B 722M 707M 31.49B
Net income	9.73M 8.55M 7.95M 7.29M 13.71M 937M 13.92M 94.39M 36.88M 461M 36.53M 35.75M 1.59B	2.99M 2.63M 2.45M 2.24M 4.22M 288M 4.28M 29.04M 11.35M 142M 11.24M 11M 490M
Net Debt	31.59M 27.74M 25.8M 23.68M 44.49M 3.04B 45.17M 306M 120M 1.5B 119M 116M 5.17B	34.19M 30.03M 27.93M 25.63M 48.15M 3.29B 48.9M 332M 130M 1.62B 128M 126M 5.6B